Plexxikon

Industry · 7 registered clinical trials.

Status	Trial	Phase	Started
Terminated	A Study of PLX51107 in Advanced Malignancies Solid Tumors, Acute Myeloid Leukemia, Myelodysplastic Syndrome	Phase 1	2016-03-01
Terminated	A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor Solid Tumors, Tenosynovial Giant Cell Tumor, Synovitis, Pigmented Villonodular	Phase 1	2016-02-01
Terminated	Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors Solid Tumor, Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations, Tenosynovial Giant Cell Tumor	Phase 1	2013-08-01
Completed	Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate Rheumatoid Arthritis	Phase 1	2011-05-01
Completed	Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PLX5622 in Healthy Adult Volunteers Healthy	Phase 1	2011-01-01
Withdrawn	Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheum Rheumatoid Arthritis	Phase 1	2010-05-01
Completed	Safety Study of PLX4032 in Patients With Solid Tumors Malignant Melanoma, Colorectal Carcinoma	Phase 1	2006-11-01